Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML

NCT07172204 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Intensive Chemotherapy Unfit
Newly Diagnosed Acute Myeloid Leukemia (AML)
Age ≥60

Interventions

DRUG: Alternately treated with VA/low CHA regimen

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

[object Object]